Mission Statement

Vision & Corporate Identity

Science refers to "symbiotics" as the study of different species of organisms that are interdependent, gaining benefits from their mutual relationships; life sciences refers to "symbiotics" as the study of human evolution based on social networking and bonding rather than natural selection; social sciences refers to "symbiotics" as the art of associating human beings for the purpose of establishing, cultivating, and conserving social life among them.

Symbiotics believes in value creation through mutually beneficial human relationships and reinforcing them. Our vision is to contribute to positive human development that grows out of social and economic connections and synergies, in particular from grassroots entrepreneurial activities.

Strategy & Target Market

The vast majority of the world population, in particular at the bottom of the pyramid, lacks the access to capital which would sustain their common association in mutually beneficial and value generating relationships. We wish to associate ourselves to initiatives that contribute to the democratization of access to capital in order to bridge this gap. Ultimately, we aim to foster free and equal value creation opportunities and, incidentally, contribute globally to an economic development which is more inclusive, socially responsible and sustainable.

To further this goal, we link socially responsible investors with low income but economically active population by working on the investment know-how and infrastructure which can bridge those two audiences. In particular, we aim at being the leading investment platform between investment funds and micro-, small and medium enterprises and institutions.

Corporate Values

Our corporate values are focused on the principles of independence, integrity and innovation; independence towards our clients and partners, integrity of our staff and work and innovation of our products and services.

In this section


Our business units
 

Legal Disclaimer: The collective investment schemes (the “Investment Products”) referred to on the following pages have not been approved for public distribution in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA) pursuant to the Swiss Collective Investment Schemes Act of 23 June 2006 (the "CISA") and its implementing regulations. Accordingly, units of such Investment Products and information, documents or material pertaining to these Investment Products on the following pages may only be distributed in or from Switzerland to qualified investors (as such term is defined in the CISA and its implementing regulations). The information, documents and material pertaining to these Investment Products on the following pages are strictly confidential and do not constitute an offer to any other person or entity than Swiss qualified investors and may only be used by those qualified investors who have accessed them. They may not be copied, used by, distributed or made available to any other person.

Similarly the information on the following pages is only intended to be viewed by persons who fall outside the scope of any law that seeks to regulate financial promotions in the country of your residence or in the country in which the content of this website is being viewed.

If you are uncertain about your position under the laws of the country in which the content of this website is being viewed then you should seek clarification by obtaining legal advice from a lawyer practicing in the country of your residence or in the country in which the content of this website is being viewed before accessing this website.

The information, documents and material contained in the following pages are not warranted to be accurate, complete, or timely. More specifically, Symbiotics SA may not be held responsible for and does not take any position with respect to the accuracy and completeness of information in the following pages.

Agree    Disagree